We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$475B
AUM Growth
+$21.4B
Cap. Flow
-$8.62B
Cap. Flow %
-1.82%
Top 10 Hldgs %
17.9%
Holding
5,783
New
811
Increased
2,514
Reduced
1,655
Closed
342

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 12.2%
3 Healthcare 9.44%
4 Consumer Discretionary 8.6%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FARM
4576
DELISTED
Farmer Brothers
FARM
$75K ﹤0.01%
2,311
+2,098
+985% +$69.3K
NTBL
4577
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$75K ﹤0.01%
+300
New +$69.7K
DLA
4578
DELISTED
Delta Apparel Inc.
DLA
$75K ﹤0.01%
+3,691
New +$76.9K
CIA icon
4579
Citizens
CIA
$194M
$74K ﹤0.01%
+10,054
New +$76.7K
CRBP icon
4580
Corbus Pharmaceuticals
CRBP
$177M
$74K ﹤0.01%
+349
New +$74.7K
ENZL icon
4581
iShares MSCI New Zealand ETF
ENZL
$83.2M
$74K ﹤0.01%
1,558
-203
-12% -$9.39K
GSK icon
4582
PUT
GSK
GSK
$104B
$74K ﹤0.01%
+1,680
New +$77.6K
PCSB
4583
DELISTED
PCSB Financial Corporation
PCSB
$74K ﹤0.01%
3,904
-490
-11% -$9.41K
WFBI
4584
DELISTED
WashingtonFirst Bankshares Inc
WFBI
$74K ﹤0.01%
+2,159
New +$75.1K
CDXS icon
4585
Codexis
CDXS
$161M
$73K ﹤0.01%
8,800
+8,740
+14,567% +$60.5K
DCO icon
4586
Ducommun
DCO
$2.94B
$73K ﹤0.01%
+2,544
New +$76.1K
LFCR icon
4587
Lifecore Biomedical
LFCR
$176M
$73K ﹤0.01%
+5,797
New +$73.3K
ASC icon
4588
Ardmore Shipping
ASC
$670M
$72K ﹤0.01%
9,058
+6,058
+202% +$50.5K
HEPA
4589
DELISTED
Hepion Pharmaceuticals
HEPA
0
XPRO icon
4590
Expro Ltd
XPRO
$2.01B
$72K ﹤0.01%
+1,792
New +$71.4K
ENZ
4591
DELISTED
Enzo Biochem, Inc.
ENZ
$72K ﹤0.01%
8,885
-15,792
-64% -$151K
NEWT icon
4592
NewtekOne
NEWT
$372M
$71K ﹤0.01%
3,865
ONIT
4593
Onity Group
ONIT
$326M
$71K ﹤0.01%
+1,522
New +$76.4K
EWD icon
4594
iShares MSCI Sweden ETF
EWD
$593M
$70K ﹤0.01%
2,060
-10
-0.5% -$349
IPAC icon
4595
iShares Core MSCI Pacific ETF
IPAC
$2.74B
$70K ﹤0.01%
1,174
+95
+9% +$5.59K
PICB icon
4596
Invesco International Corporate Bond ETF
PICB
$360M
$70K ﹤0.01%
+2,522
New +$68.2K
TNK icon
4597
Teekay Tankers
TNK
$2.64B
$70K ﹤0.01%
6,322
+5,727
+963% +$70.4K
LTS
4598
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$70K ﹤0.01%
22,216
+22,212
+555,300% +$68.9K
EBTC
4599
DELISTED
Enterprise Bancorp
EBTC
$69K ﹤0.01%
+2,041
New +$73.1K
NTLA icon
4600
Intellia Therapeutics
NTLA
$1.68B
$69K ﹤0.01%
+3,595
New +$83K

Similar funds

JP Morgan Chase's Q4 2017 Portfolio in Review

As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
  • JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
  • JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
  • JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
  • JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
  • JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.